Learn The Latest In Gene Editing
Resources to help you learn more about the latest in gene editing technology in various industries. Choose your area of research below.
Demeetra AgBio has completed the full integration of Hera BioLabs, expanding Demeetra’s rights to the hyperactive Super piggyBac transposase platform ...
Landing Pad Methods for Next-Generation Cell Line Development We are releasing a new white paper demonstrating that Cas-CLOVER enables ...
𝐂𝐚𝐬-𝐂𝐋𝐎𝐕𝐄𝐑 𝐢𝐬 𝐦𝐨𝐫𝐞 𝐭𝐡𝐚𝐧 𝐠𝐞𝐧𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠, 𝐢𝐭’𝐬 𝐚 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐚𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞. At BioProcess International Fall Digital Week 2025, Demeetra presented: ...
LEXINGTON, KY — November 11, 2025 — Demeetra AgBio announced that its flagship CleanCut GS CHO cell line has tested clean on two ...
Bioprocessing International (BPI) 2025 Multiplexing with Accuracy: Building Better CHO Platforms with Cas-CLOVER Speaker: Corey Brizzee, Director, Gene Editing, Demeetra ...
Bioprocessing Summit 2025 Multiplexing with Accuracy: Building Better CHO Platforms with Cas-CLOVER Speaker: Corey Brizzee, Director, Gene Editing, Demeetra ...
Protein Engineering and Genomics (PEGS) 2025 Enhancing Genome Editing Capabilities: Unveiling the Advantages of Cas-CLOVER over CRISPR/Cas9 Speaker: Corey Brizzee, ...
Bioprocessing International (BPI) Europe Unveiling the Complementary Benefits of Cas-CLOVER Dimeric Nuclease and Harbor-IN License-Free Transposase Speaker: Cintia Gómez, Ph.D., ...
Bioprocessing International (BPI) West Enhancing Genome Editing Capabilities: Unveiling the Advantages of Cas-CLOVER over CRISPR/Cas9 Speaker: Corey Brizzee, Director, Gene ...
Bioprocessing International (BPI) 2024 Undeniable CRISPR FTO: Combining Cas-CLOVER IP with Foundational CRISPR/Cas9 IP from the CVC Speaker: Jack Crawford, ...
May 12–16, 2025 Hynes Convention Center | Boston, MA We’re bringing our latest innovations in gene editing and cell line ...
May 12-15, 2025 Congress Center Hamburg | Hamburg, Germany We're heading to Hamburg! Demeetra will be on site at BioProcess ...
We Enable Scientists To Obtain More With Less Inconvenience
Contact us to learn more about our gene editing technology.